Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $33.4100 (0.54%) ($32.7000 - $34.0500) on Thu. Apr. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 21 | Latest Price | $33.4100(0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.8% in a week (0% probabilities). UUP(-14%) VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
1 - 5 Day Possible Target | $18.26(-45.35%) | Resistance Level | $36.42 | 5 Day Moving Average | $32.74(2.05%) | 10 Day Moving Average | $33.87(-1.36%) | 20 Day Moving Average | $36.42(-8.26%) | To recent high | -20% | To recent low | 5.4% | Market Cap | $2.483b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |